Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Patients With Chronic Kidney Disease
Conditions:   Anemia;   Chronic Kidney Disease;   Kidney DiseaseInterventions:   Drug: Darbepoetin Alfa;   Drug: PlaceboSponsor:   AmgenTerminated - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 15, 2007 Category: Research Source Type: clinical trials

COMFORT Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia.
Condition:   AnemiaInterventions:   Drug: darbepoetin alfa;   Drug: epoetin beta [NeoRecormon]Sponsor:   Hoffmann-La RocheCompleted - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 15, 2006 Category: Research Source Type: clinical trials

COMFORT Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia.
Condition:   AnemiaInterventions:   Drug: darbepoetin alfa;   Drug: epoetin beta [NeoRecormon]Sponsor:   Hoffmann-La RocheCompleted - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 15, 2006 Category: Research Source Type: clinical trials

COMFORT Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia.
Condition:   AnemiaInterventions:   Drug: darbepoetin alfa;   Drug: epoetin beta [NeoRecormon]Sponsor:   Hoffmann-La RocheCompleted - verified June 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 15, 2006 Category: Research Source Type: clinical trials

COMFORT Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia.
Condition:   AnemiaInterventions:   Drug: darbepoetin alfa;   Drug: epoetin beta [NeoRecormon]Sponsor:   Hoffmann-La RocheCompleted - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 15, 2006 Category: Research Source Type: clinical trials

COMFORT Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia.
Condition:   AnemiaInterventions:   Drug: darbepoetin alfa;   Drug: epoetin beta [NeoRecormon]Sponsor:   Hoffmann-La RocheCompleted - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 15, 2006 Category: Research Source Type: clinical trials

COMFORT Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia.
Condition:   AnemiaInterventions:   Drug: darbepoetin alfa;   Drug: epoetin beta [NeoRecormon]Sponsor:   Hoffmann-La RocheCompleted - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 15, 2006 Category: Research Source Type: clinical trials